# The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

> **NCT04559945** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 326 (actual)

## Conditions studied

- Cardiac Rhythm Disorder
- Bradycardia

## Interventions

- **DEVICE:** Aveir VR Leadless Pacemaker System

## Key facts

- **NCT ID:** NCT04559945
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-13
- **Primary completion:** 2022-07-18
- **Final completion:** 2023-08-31
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559945, "The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04559945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*